Rockwell Medical a fully-integrated biopharmaceutical company offering innovative products and services targeting End-Stage Renal Disease (ESRD), Chronic Kidney Disease (CKD), and iron deficiency anaemia, announced that it has executed a multi-year supply agreement with DaVita Inc. through 2013.
Robert L Chioini, chairman and CEO of Rockwell Medical, stated that, “We are pleased to have executed this multi-year supply agreement with DaVita, further strengthening our long-standing business relationship. We are proud to provide high-quality products and premium customer and delivery service to dialysis providers committed to offering top-level patient care, such as DaVita.”
DaVita Inc., a Fortune 500 company, is a leading provider of kidney care in the United States, delivering dialysis services and education to patients with chronic kidney failure and end stage renal disease. As of December 31, 2010, DaVita operated or provided administrative services at 1,612 dialysis facilities, serving approximately 125,000 patients.